Anti-vascular endothelial growth factor： the future treatment of choroidal neovascularization in pathologic myopia  

作　　者：ZHU Hong WANG Feng-hua SUN Xiao-dong 

机构地区：[1]Department of Ophthalmology, Shanghai First People's Hospital,School of Medicine, Shanghai Jiao Tong University, Shanghai200080, China [2]Shanghai Key I~abomtory of Fundus Disease, Eye Research Instituteof Shanghai Jiao Tong University, Shanghai 200080, China

出　　处：《Chinese Medical Journal》2013年第8期1578-1583,共6页中华医学杂志（英文版）

基　　金：This study was supported by grants from the China National Basic Research Program （973 Program, No. 2011CB707506）, China National Natural Science Foundation （No. 81271030 and No. 81100678）, Shanghai Key Basic Research Grant （No. 11JC141601）, Shanghai Scholar Leadship Grant （No. 12XD1404100）, and Shanghai Committee of Science and Technology Guide Grant （No. 114119a7000）.

摘　　要：-yopia is the most common refractive disorder. High .myopia affects 27%-33% of all myopic eyes inAsia.1,2 ;The pathologic myopia （PM） is the most severe vision-threatening phenotype of high myopia.3 It is also the second most common cause of choroidal neovascularization （CNV） in Asia. Unlike age-related macular degeneration （AMD） which mostly effecting elders, PM causes severe vision loss in young adults, resulting in a significant impairment of their working ability.4 PM has become the second leading cause of low vision and blindness particularly among those aged at 40-49 years in some Asia countries.-yopia is the most common refractive disorder. High .myopia affects 27%-33% of all myopic eyes inAsia.1,2 ;The pathologic myopia （PM） is the most severe vision-threatening phenotype of high myopia.3 It is also the second most common cause of choroidal neovascularization （CNV） in Asia. Unlike age-related macular degeneration （AMD） which mostly effecting elders, PM causes severe vision loss in young adults, resulting in a significant impairment of their working ability.4 PM has become the second leading cause of low vision and blindness particularly among those aged at 40-49 years in some Asia countries.

关 键 词：choroidal neovascular anti-vascular endothelial growth factor treatment  pathologic myopia 

分 类 号：Q78[生物学—分子生物学] S966.35[农业科学—水产养殖]